Ribavirin for hepatitis c

Common Questions and Answers about Ribavirin for hepatitis c

rebetol

Avatar m tn We are finally winning this war against this virus that has caused so much suffering to so many. For the many millions of people infected with hepatitis C the future is more hopeful than ever before.
Avatar f tn there are no doctors here. there is medicine that can cure hepatitis C. it is a combo called interferon & ribavirin. in about a year there will be new drugs that when added to the present drugs offer even a better cure for hepatitis c.
Avatar m tn //www.hivandhepatitis.
Avatar m tn Others not yet Recruiting for Sofosbuvir 1 Not yet recruiting Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 Condition: Chronic Hepatitis C Genotype 1 Intervention: Drug: SOF 400 mg once daily + TVR 1125mg BID for 12 weeks 2 Not yet recruiting Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection Condition: HCV Infection Interventions: Drug: SOF/LDV; Drug: RBV; Drug
Avatar m tn Ja imam hepatitis c gen1 oko 20god. osecam se veoma lose,fibroza je f3 imam bolove u desnom delu stomaka,stalno me boli glava,malaksalost,umor,oci mi dosta suze ... Terapija interferon+ribavirin 48 nedelja je bila neuspesna.
Avatar n tn Upon analyzing over 3,000 people being treated for Hepatitis C with pegylated interferon and ribavirin, Mark Sulkowski and colleagues found this to be true even when ribavirin reduction or ESA administration was given to reduce anemia. In fact, the rates of achieving a sustained virological response were greater as the severity of the anemia increased.
348159 tn?1233169707 Hep c is treatable. The treatment today is Interferon shots once a week and several Ribavirin pills every day. The length of treatment is either 24 or 48 weeks depending on the Genotype of Hep c that the patient has. There is a lot to do before treatment. The patient needs to go to a specialist either a Gastro or hepatoligist. They will do blood work to determine what type of Hep c and how much damage has been caused. And then they will either recommend for or against treatment.
Avatar f tn Bristol-Myers Squibb Announces Acceptance of New Drug Application for Investigational Daclatasvir for FDA Review for the Treatment of Hepatitis C Genotype 3 The NDA contains data to support approval for daclatasvir in combination with sofosbuvir; would be the first 12-week regimen specifically for the treatment of hepatitis C genotype 3 The application is based on a Phase III clinical trial which tested a 12-week, ribavirin-free regimen and resulted in sustained virologic response (SVR12) in
4043517 tn?1374006573 Promacta, in combination with interferon and ribavirin in patients with chronic hepatitis C, may increase the risk of hepatic decompensation. Patients receiving therapy with Promacta must have regular monitoring of serum liver tests.
476246 tn?1418870914 26June2008 Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.
Avatar f tn //www.medhelp.org/health_pages/Hepatitis/Hepatitis-C-Acronyms-Abbreviations/show/3?